HIV molecular immunology database

 

Patient Detail

Patient Code 2x0226
Patient Sex Male
Risk Factor Sex with male (SM)
Infection Country US
Infection City
Infection Year
HLA Type
Patient Ethnicity Other
Progression
Species human
Patient Note Subject 2x0226, 31 years old, who participated in a vaccine trial, acquired HIV within 215 days of administration of vaccine vCP205/gp160, 4 times. Response to epitopes Vif and Env PIPIHYCAPAGFAIL by EliSpot was 2,943 and 153 SFU /106 PBMC, 30d post-infection (dpi). [Horton2006a, PMID: 16973582].
CTL CD8+ Records 54930, 54931
T-Helper CD4+ Records
Antibody Records
Sequence Database Patient ID Record
Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health